|The KRT19 krt19 (Catalog #MBS4380083) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker) reacts with Human, Mouse. Others not known. and may cross-react with other species as described in the data sheet. MyBioSource\'s Cytokeratin 19 (KRT19) can be used in a range of immunoassay formats including, but not limited to, Flow Cytometry (FC/FACS), Immunofluorescence (IF), Immunohistochemistry (IHC) Formalin.
FC/FACS: 0.5-1ug/million cells
IHC-F: 0.5-1ug/ml for 30 min at RT; Staining of formalin-fixed tissues requires boiling tissue sections in 10mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes. Researchers should empirically determine the suitability of the KRT19 krt19 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The KRT19 krt19 product has the following accession number(s) (GI #24234699) (NCBI Accession #NP_002267.2) (Uniprot Accession #P08727). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker) with the following immunoassay(s):
Immunohistochemistry (IHC) (Formalin-fixed, paraffin-embedded human Colon stained with Cytokeratin 19 Rabbit Recombinant Monoclonal Antibody (KRT19/1959R).)
SDS-Page (SDS-PAGE Analysis of Purified Cytokeratin 19 Rabbit Recombinant Monoclonal Antibody (KRT19/1959R).)
Immunogen: Recombinant full-length human KRT19 protein
Cellular Localization: Cytoplasmic. Hu-chromosome Location: 17q21.2
Positive Control: MCF-7, HeLa cells, Breast Cancer. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing KRT19 are readily searchable from our website. Different antibodies against the same target such as KRT19 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Blood, Bone, Eye, Kidney, Liver, Lung, Lymph, Pancreas, Stomach, Thyroid tissues are correlated with this protein. Adenocarcinoma, Breast Neoplasms, Carcinoma, Carcinoma, Hepatocellular, Fibrosis, Kidney Diseases, Liver Diseases, Liver Neoplasms, Neoplasm Metastasis, Neoplasms are some of the diseases may be linked to Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker). The following patways have been known to be associated with this gene. KRT19 also interacts with the following gene(s): FANCG, KRT15, KRT6B.